NZ195933A - Sustained-release pharmaceutical compositions in tablet form - Google Patents

Sustained-release pharmaceutical compositions in tablet form

Info

Publication number: NZ195933A
Authority: NZ; New Zealand
Prior art keywords: sustained; pharmaceutical compositions; release pharmaceutical; tablet form; tablet
Prior art date: 1980-01-11

Application number

NZ195933A

Inventor

J Dunn

J Lampard

Original Assignee

Boots Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1980-01-11

Filing date

1980-12-23

Publication date

1982-11-23

1980-10-17 Priority claimed from US06/194,453 external-priority patent/US4308251A/en

1980-12-23 Application filed by Boots Co Ltd filed Critical Boots Co Ltd

1982-11-23 Publication of NZ195933A publication Critical patent/NZ195933A/en

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

NZ195933A 1980-01-11 1980-12-23 Sustained-release pharmaceutical compositions in tablet form NZ195933A (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US11143080A	1980-01-11	1980-01-11
US06/194,453 US4308251A (en)	1980-01-11	1980-10-17	Controlled release formulations of orally-active medicaments

Publications (1)

Publication Number	Publication Date
NZ195933A true NZ195933A (en)	1982-11-23

Family

ID=26808896

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NZ195933A NZ195933A (en)	1980-01-11	1980-12-23	Sustained-release pharmaceutical compositions in tablet form

Country Status (22)

Country	Link
JP (1)	JPS56103110A (en)
AT (1)	AT374681B (en)
AU (1)	AU542824B2 (en)
BE (1)	BE886998A (en)
CA (1)	CA1140466A (en)
CH (1)	CH646604A5 (en)
DE (1)	DE3100191A1 (en)
DK (1)	DK6181A (en)
ES (2)	ES8205353A1 (en)
FI (1)	FI76927C (en)
FR (1)	FR2473308B1 (en)
GB (1)	GB2067072B (en)
GR (1)	GR73843B (en)
IE (1)	IE50806B1 (en)
IN (1)	IN151913B (en)
IT (1)	IT1221041B (en)
LU (1)	LU83052A1 (en)
NL (1)	NL8100037A (en)
NO (1)	NO156153C (en)
NZ (1)	NZ195933A (en)
SE (1)	SE447450B (en)
ZA (1)	ZA81136B (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2496082A (en) *	1947-05-24	1950-01-31	Ashenfelter William	Scaffold structure
IT1144911B (en) *	1981-03-19	1986-10-29	Pharmatec Spa	CONTROLLED RELEASE PHARMACEUTICAL COMPOSITION CONTAINING IBUPROFEN
JPS59227817A (en) *	1983-06-07	1984-12-21	Toyo Jozo Co Ltd	Long-acting bredinin preparation for oral administration
JPH0662404B2 (en) *	1983-06-14	1994-08-17	シンテックス・ファーマシユーテイカルズ・インターナシヨナル・リミテツド	Controlled-release naproxen and naproxen sodium tablets
ZA836030B (en) *	1983-08-16	1985-02-27	Verex Lab	Constant order release solid dosage indomethacin formulation and method of treating arthritis and other inflammatory conditions
ZA836031B (en) *	1983-08-16	1985-02-27	Verex Lab	Constant release rate solid dosage theophylline formulation
US5385738A (en) *	1983-10-14	1995-01-31	Sumitomo Pharmaceuticals Company, Ltd.	Sustained-release injection
EP0138216B1 (en) *	1983-10-14	1993-01-07	Sumitomo Pharmaceuticals Company, Limited	Sustained-release ifn preparation for parenteral administration
US4774091A (en) *	1983-10-14	1988-09-27	Sumitomo Pharmaceuticals Company, Ltd.	Long-term sustained-release preparation
US4855134A (en) *	1983-10-14	1989-08-08	Sumitomo Pharmaceuticals Company, Limited	Sustained-release preparation
ES2054613T3 (en) *	1985-12-27	1994-08-16	Sumitomo Pharma	A METHOD FOR PREPARING A MAINTENANCE RELEASE FORMULATION.
GB8601204D0 (en) *	1986-01-18	1986-02-19	Boots Co Plc	Therapeutic agents
IL85538A (en) *	1987-02-27	1991-09-16	Lilly Co Eli	Sustained release matrix tablet formulations containing hydrophilic and enteric polymers
US4968508A (en) *	1987-02-27	1990-11-06	Eli Lilly And Company	Sustained release matrix
US5855915A (en)	1995-06-30	1999-01-05	Baylor University	Tablets or biologically acceptable implants for long-term antiinflammatory drug release

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2953497A (en) *	1953-06-03	1960-09-20	Howard A Press	Therapeutic tablets
NL128902C (en) *	1960-06-06
US3577514A (en) *	1968-06-10	1971-05-04	Pfizer	Sustained release pharmaceutical tablets
US3773920A (en) *	1971-07-14	1973-11-20	Nikken Chemicals Co Ltd	Sustained release medicinal composition
US3906086A (en) *	1971-07-19	1975-09-16	Richard G Powers	Timed-release aspirin
GB1500300A (en) *	1975-01-06	1978-02-08	Ciba Geigy Ag	Pharmaceutical preparation for the treatment of circulatory disorders
JPS5411226A (en) *	1977-06-24	1979-01-27	Shin Etsu Chem Co Ltd	Disintegratable granule

1980
- 1980-12-23 IN IN1418/CAL/80A patent/IN151913B/en unknown
- 1980-12-23 NZ NZ195933A patent/NZ195933A/en unknown
1981
- 1981-01-05 AU AU65976/81A patent/AU542824B2/en not_active Ceased
- 1981-01-06 FR FR8100087A patent/FR2473308B1/en not_active Expired
- 1981-01-07 DE DE19813100191 patent/DE3100191A1/en active Granted
- 1981-01-07 NL NL8100037A patent/NL8100037A/en not_active Application Discontinuation
- 1981-01-08 GB GB8100522A patent/GB2067072B/en not_active Expired
- 1981-01-08 CH CH9281A patent/CH646604A5/en not_active IP Right Cessation
- 1981-01-08 BE BE0/203426A patent/BE886998A/en unknown
- 1981-01-08 ES ES498369A patent/ES8205353A1/en not_active Expired
- 1981-01-08 DK DK6181A patent/DK6181A/en not_active Application Discontinuation
- 1981-01-08 JP JP157881A patent/JPS56103110A/en active Pending
- 1981-01-09 AT AT0005481A patent/AT374681B/en not_active IP Right Cessation
- 1981-01-09 SE SE8100104A patent/SE447450B/en not_active IP Right Cessation
- 1981-01-09 IT IT47537/81A patent/IT1221041B/en active
- 1981-01-09 ZA ZA00810136A patent/ZA81136B/en unknown
- 1981-01-09 NO NO810062A patent/NO156153C/en unknown
- 1981-01-09 GR GR63828A patent/GR73843B/el unknown
- 1981-01-09 LU LU83052A patent/LU83052A1/en unknown
- 1981-01-09 IE IE36/81A patent/IE50806B1/en unknown
- 1981-01-09 CA CA000368219A patent/CA1140466A/en not_active Expired
- 1981-01-09 FI FI810056A patent/FI76927C/en not_active IP Right Cessation
1982
- 1982-01-29 ES ES509179A patent/ES8301629A1/en not_active Expired

Also Published As

Publication number	Publication date
AT374681B (en)	1984-05-25
NO810062L (en)	1981-07-13
IT8147537A0 (en)	1981-01-09
ATA5481A (en)	1983-10-15
JPS56103110A (en)	1981-08-18
DK6181A (en)	1981-07-12
DE3100191C2 (en)	1988-09-01
IT1221041B (en)	1990-06-21
ES509179A0 (en)	1982-12-16
AU6597681A (en)	1981-07-16
FR2473308B1 (en)	1985-07-19
ES8301629A1 (en)	1982-12-16
NO156153B (en)	1987-04-27
FR2473308A1 (en)	1981-07-17
BE886998A (en)	1981-07-08
CA1140466A (en)	1983-02-01
FI810056L (en)	1981-07-12
ES498369A0 (en)	1982-06-01
AU542824B2 (en)	1985-03-14
SE8100104L (en)	1981-07-12
DE3100191A1 (en)	1981-12-10
GB2067072B (en)	1983-08-10
IE50806B1 (en)	1986-07-23
ES8205353A1 (en)	1982-06-01
GB2067072A (en)	1981-07-22
IN151913B (en)	1983-09-03
FI76927C (en)	1989-01-10
LU83052A1 (en)	1982-09-10
NL8100037A (en)	1981-08-03
NO156153C (en)	1987-08-05
FI76927B (en)	1988-09-30
SE447450B (en)	1986-11-17
GR73843B (en)	1984-05-07
IE810036L (en)	1981-07-11
CH646604A5 (en)	1984-12-14
ZA81136B (en)	1982-01-27

Publication	Publication Date	Title
ZA813465B (en)	1982-06-30	Pharmaceutical composition
ZA816272B (en)	1982-09-29	Pharmaceutical formulation
IL66435A0 (en)	1982-12-31	Sustained-release pharmaceutical compositions
GB8428369D0 (en)	1984-12-19	Pharmaceutical tablets
GB8315489D0 (en)	1983-07-13	Stable pharmaceutical tablet
ZA824622B (en)	1983-04-27	Pharmaceutical compositions
NZ195933A (en)	1982-11-23	Sustained-release pharmaceutical compositions in tablet form
PH17562A (en)	1984-10-01	2-guanidino-4-heteroarylthiazoles and pharmaceutical compositions
ZA825397B (en)	1983-06-29	Pharmaceutical compositions
ZA816766B (en)	1982-09-29	Anti-ischaemic pharmaceutical compositions
ZA822856B (en)	1983-03-30	Pharmaceutical compositions
ZA82652B (en)	1983-01-26	Pharmaceutical compositions
GB2072504B (en)	1983-10-26	Pharmaceutical compositions
GB2067900B (en)	1983-06-22	Medicinal tablets
ZA815700B (en)	1982-08-25	Pharmaceutical compositions
IL62517A (en)	1984-01-31	Pharmaceutical compositions comprising cisplatin
DE3176849D1 (en)	1988-09-29	Pharmaceutical composition comprising 4-carbamoyl-imidazolium-5-olate
ZA817684B (en)	1982-10-27	Pharmaceutical compositions
HK90087A (en)	1987-12-11	Pharmaceutical formulation
ZA814056B (en)	1982-09-29	Pharmaceutical bicyclo-octatriene compounds and compositions
SG59387G (en)	1987-10-23	Pharmaceutical compositions
ZA826479B (en)	1984-04-25	Pharmaceutical compositions
ZA815175B (en)	1982-09-29	Pharmaceutical composition
AU87660S (en)	1983-09-20	Pharmaceutical tablet
ZA82186B (en)	1982-11-24	Pharmaceutical compositions